is a topic covered in the Johns Hopkins ABX Guide
To view the entire topic, please sign in or purchase a subscription.
Official website of the Johns Hopkins Antibiotic (ABX), HIV, Diabetes, and Psychiatry Guides, powered by Unbound Medicine. Johns Hopkins Guide App for iOS, iPhone, iPad, and Android included. Explore these free sample topics:
-- The first section of this topic is shown below --
- Prevention of serious lower respiratory tract disease caused by respiratory syncytial virus (RSV) in pediatric patients at high risk of RSV disease (bronchopulmonary dysplasia, premature birth, and hemodynamically significant congenital heart disease).
- Treatment of serious RSV pneumonia in immunocompromised adult patients (limited data).
-- To view the remaining sections of this topic, please sign in or purchase a subscription --
Last updated: November 2, 2015
Pham, Paul A. "Palivizumab." Johns Hopkins ABX Guide, The Johns Hopkins University, 2015. Johns Hopkins Guide, www.hopkinsguides.com/hopkins/view/Johns_Hopkins_ABX_Guide/540413/all/Palivizumab.
Pham PA. Palivizumab. Johns Hopkins ABX Guide. The Johns Hopkins University; 2015. https://www.hopkinsguides.com/hopkins/view/Johns_Hopkins_ABX_Guide/540413/all/Palivizumab. Accessed November 16, 2019.
Pham, P. A. (2015). Palivizumab. In Johns Hopkins ABX Guide. Available from https://www.hopkinsguides.com/hopkins/view/Johns_Hopkins_ABX_Guide/540413/all/Palivizumab
Pham PA. Palivizumab [Internet]. In: Johns Hopkins ABX Guide. The Johns Hopkins University; 2015. [cited 2019 November 16]. Available from: https://www.hopkinsguides.com/hopkins/view/Johns_Hopkins_ABX_Guide/540413/all/Palivizumab.
TY - ELEC
T1 - Palivizumab
ID - 540413
A1 - Pham,Paul,Pharm.D. BCPS
Y1 - 2015/11/02/
BT - Johns Hopkins ABX Guide
UR - https://www.hopkinsguides.com/hopkins/view/Johns_Hopkins_ABX_Guide/540413/all/Palivizumab
PB - The Johns Hopkins University
DB - Johns Hopkins Guide
DP - Unbound Medicine